ChartRow logo
Share this page
ORIC
$12.35-3.29%
as of close, Oct 16, 2026
☾ AH $12.35 -3.29%
PeersMRNALLYMDTUNHJNJTMO

Oric Pharmaceuticals Inc. trailing returns

How Oric Pharmaceuticals Inc. (ORIC) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-3.3%+0.0%-3.3%—
5 days+3.0%+0.0%+3.0%-5.7%Oct 13
1 month-1.5%+0.0%-1.5%-16.2%Oct 13
YTD+51.0%+0.0%+51.0%-46.1%Apr 1
1 year-7.1%+0.0%-7.1%-46.1%Apr 2026
5 years-5.3%+0.0%-5.3%-23.9%-86.2%Nov 2022
Since inception (2020)-10.7%+0.0%-10.7%-52.1%-93.9%Nov 2022

Growth of ORIC#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-5.3%/year · -23.9%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in ORIC's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Oric Pharmaceuticals Inc.'s return since inception?
Since 2020, Oric Pharmaceuticals Inc. (ORIC) has compounded at about -10.7% a year — -52.1% in total.

More on Oric Pharmaceuticals Inc.